The Cuban drug Jusvinza is advancing to the second phase of clinical trials, demonstrating its effectiveness in relieving pain and inflammation in secondary joints in patients recovering from the chikungunya virus.
This was reported by Julio Baldomero, director of Clinical Research at the Center…
Read More...
